Chemours Company (The) ($CC) Stock Forecast: Up 5.5% Today

What is Chemours Company (The)?

Chemours (CC) operates in the chemical industry, renowned for its innovative solutions and products. The stock displayed a strong bullish movement today, reflecting positive market sentiment.

Why is Chemours Company (The) going up?

CC stock is up 5.5% on Feb 27, 2026 20:21

• Chemours (CC) experienced a bullish trend today due to investor focus on the company's new AI cooling partnership and analyst updates.
• The successful private offering of $700 million in senior notes due 2034 also contributed to the positive market movement.
• Despite concerns raised by a law firm regarding potential securities fraud and market headwinds, the company's undervaluation according to discounted cash flow models and price-to-sales ratios has helped reassure investors.
• The company's valuation and recent financial results have inspired volatility, but the overall market sentiment remains optimistic about Chemours' future prospects.

CC Price Chart

CC Technical Analysis

CC News

A Look At Chemours (CC) Valuation As New AI Cooling Partnership And Analyst Updates Refocus Investor Attention

Chemours (CC) has captured investor attention due to a new joint development agreement with 2CRSi for AI data center cooling and updated analyst views. The stock's recent performance shows a slowdown after a strong period, trading near the average analyst target. While a narrative suggests Chemours is slightly overvalued, a discounted cash flow model points to a significant undervaluation, highlighting mixed signals for investors to consider.

https://simplywall.st/stocks/us/materials/nyse-cc/chemours/news/a-look-at-chemours-cc-valuation-as-new-ai-cooling-partnershi

Chemours raises $700M at 7.875% to refinance 2027, 2028 notes

Chemours (NYSE: CC) has priced an upsized private offering of $700 million in 7.875% senior notes due March 15, 2034, increased from a previously announced $600 million. The company intends to use the net proceeds to redeem its outstanding 5.375% senior notes due 2027 and partially redeem its 5.750% senior notes due 2028. The offering is expected to close on March 12, 2026, and interest will be paid semi-annually starting September 15, 2026.

https://www.stocktitan.net/news/CC/the-chemours-company-announces-upsizing-and-pricing-of-private-opyqywtf001b.html

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC

Pomerantz LLP is investigating The Chemours Company (NYSE: CC) after its stock price fell significantly following the announcement of its fourth-quarter and full-year 2025 financial results. The decline was attributed to a one-time inventory charge and "short-term cyclical end market headwinds" in its Advanced Performance Materials segment. The law firm is examining potential securities fraud or unlawful business practices by Chemours and its officers.

https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-the-chemours-company---cc-302698886.html

The Chemours Company Announces Upsizing and Pricing of Private Offering of $700,000,000 of 7.875% Senior Notes Due 2034

The Chemours Company has announced the upsizing and pricing of a private offering of $700,000,000 aggregate principal amount of 7.875% senior notes due 2034. The offering size was increased from $600,000,000, and the notes will bear interest semi-annually. Chemours plans to use the net proceeds to redeem its outstanding 5.375% senior notes due 2027 and partially redeem its 5.750% senior notes due 2028.

https://finviz.com/news/324357/the-chemours-company-announces-upsizing-and-pricing-of-private-offering-of-700000000-of-7875-senior-notes-due-2034

Is Chemours (CC) Pricing Reflect Recent Volatility And Discounted Cash Flow Outlook

This article analyzes Chemours (CC) stock valuation using discounted cash flow (DCF) and price-to-sales (P/S) ratios, concluding it is undervalued. The DCF model estimates a 63.6% discount, while the P/S ratio suggests it is inexpensive compared to industry peers and its proprietary "Fair Ratio." The article also presents "Bull" and "Bear" case narratives for Chemours, highlighting different future outlooks based on revenue growth, PFAS legal risks, and market expectations.

https://simplywall.st/stocks/us/materials/nyse-cc/chemours/news/is-chemours-cc-pricing-reflect-recent-volatility-and-discoun

Trending Today

Bitcoin ($BTC) Crypto Forecast: Up 5.7% Today

Estee Lauder Companies Inc. (The) ($EL) Stock Forecast: Down 4.1% Today

SoFi Technologies Inc. ($SOFI) Stock Forecast: Up 5.1% Today

Steel Dynamics Inc. ($STLD) Stock Forecast: Up 5.2% Today

Lucid Motors Inc. ($LCID) Stock Forecast: Up 5.3% Today

Western Digital Corporation ($WDC) Stock Forecast: Down 5.1% Today

Moderna Inc. ($MRNA) Stock Forecast: Up 5.6% Today

Ethereum ($ETH) Crypto Forecast: Up 5.6% Today

Digital Ocean Holdings ($DOCN) Stock Forecast: Up 5.3% Today

Jefferies Financial Group Inc. ($JEF) Stock Forecast: Up 5.0% Today

Chemours Company (The) Price History

20.01.2026 - CC Stock was down 18.3%

• Chemours (CC) encountered a noticeable earnings shortfall in Q4, primarily due to decreasing sales and profitability in its Advanced Performance Materials sector.
• Despite seeing growth in data-center cooling markets, the disappointing earnings report caused a significant drop in Chemours' stock value.
• Although the company made strategic moves to expand in Thermal & Specialized Solutions and Advanced Performance Materials, the lackluster Q4 performance in the APM segment took the spotlight.
• Chemours' failure to meet earnings expectations and the subsequent decline in its stock price underscore the challenges in the APM division, prompting concerns about the company's financial condition and distress signals.

20.01.2026 - CC Stock was down 21.2%

• Chemours (CC) experienced a notable Q4 earnings shortfall, attributed to a decline in sales and profitability within its Advanced Performance Materials segment, resulting in a downturn in the market.
• Despite an uptick in data-center cooling markets, disappointing Q4 performance and earnings contributed to a substantial drop in Chemours' stock value.
• The company's failure to meet estimated Q4 adjusted EPS as per FactSet and the announcement of reduced earnings and sales intensified bearish sentiments.
• Going forward, Chemours projects revenue growth in 2026 driven by Opteon™ Refrigerants demand and cost-saving initiatives, potentially reversing the current downward trajectory of the stock.

20.01.2026 - CC Stock was down 14.3%

• CC reported Q4 earnings that fell short of analyst estimates, with adjusted EPS at $0.05 compared to the expected $0.07, and revenue of $1.3 billion missing the estimated $1.33 billion.
• Despite the earnings miss, the stock experienced significant growth in the last three months, up 84.71%, and 16.76% in the last twelve months, indicating positive investor sentiment prior to the recent earnings report.
• The company attributed the net loss in Q4 and full year to lower cost absorption, non-cash inventory charges, and litigation-related expenses, impacting its financial performance.
• Chemours Co. anticipates future growth in net sales and adjusted EBITDA for 2026, driven by Opteon™ Refrigerants demand and strategic cost reductions, providing a positive outlook despite the current earnings disappointment.

23.01.2026 - CC Stock was up 5.2%

• The stock of Chemours (CC) experienced a strong bullish movement today.
• Positive adjustments to price targets and ratings likely boosted investor confidence in the company's future prospects.
• Despite facing challenges such as disappointing Q4 earnings and ongoing litigation, Chemours' focus on implementing pricing actions and divesting assets to strengthen its financial position seems to have resonated positively with investors.
• The company's projected consolidated net sales growth for 2026 and improved adjusted EBITDA and free cash flow outlook might have contributed to the bullish sentiment surrounding the stock today.

24.01.2026 - CC Stock was up 5.0%

• Chemours Co reported a net loss mainly attributed to litigation-related charges and increased costs, impacting its financial performance negatively in its annual Form 10-K report.
• Despite the loss, Chemours is working on strengthening its ties with the semiconductor industry, increasing adoption of its Opteon refrigerants, and streamlining its portfolio through asset sales for debt reduction.
• The company is encountering operational challenges and legal issues, including a lawsuit regarding PFAS contamination. This situation might have influenced the negative market sentiment, although there is anticipated support from its Opteon product line as Jefferies raised its stock price target.

27.01.2026 - CC Stock was up 5.5%

• Chemours (CC) experienced a bullish trend today due to investor focus on the company's new AI cooling partnership and analyst updates.
• The successful private offering of $700 million in senior notes due 2034 also contributed to the positive market movement.
• Despite concerns raised by a law firm regarding potential securities fraud and market headwinds, the company's undervaluation according to discounted cash flow models and price-to-sales ratios has helped reassure investors.
• The company's valuation and recent financial results have inspired volatility, but the overall market sentiment remains optimistic about Chemours' future prospects.

04.01.2026 - CC Stock was up 9.1%

• Chemours' bullish market movement today could be attributed to the company's efforts to improve its financial health by divesting assets and appointing new leadership to drive a turnaround in its Titanium Technologies segment.
• The surge in Chemours' share price may also be influenced by investors reacting positively to the company's actions to address its operational challenges and environmental liabilities.
• Despite concerns about limited growth potential and job cuts at mining facilities, the market may be optimistic about Chemours' future prospects based on the recent developments and potential for improved efficiency in operations.
• The technical analysis and AI-generated trading strategies highlighting a risk-reward setup and distinct trading strategies could have also contributed to the bullish momentum in Chemours' stock today.

06.01.2026 - CC Stock was up 5.5%

• Chemours (CC) stock saw a bullish trend today, possibly driven by the anticipation surrounding its upcoming fourth-quarter 2025 earnings release and conference call.
• The market may be reacting positively to the potential for long-term prospects, especially in the titanium dioxide (TiO2) business, despite analysts' expectations of a decline in EPS and revenue for the quarter.
• The announcement of a sustainable 2% yield for Chemours could have also contributed to investor interest in the stock, emphasizing the importance of dividends for total stock market returns.
• Overall, the bullish movement in CC's stock today could be a reflection of investor optimism towards the company's future performance and strategic initiatives, despite near-term challenges.

05.01.2026 - CC Stock was down 5.0%

• The company announced its fourth-quarter 2025 financial results, with analysts expecting a decline in earnings per share and revenue from the previous quarter, influencing the bearish movement in the stock.
• Despite long-term optimism surrounding potential market turnarounds in its titanium dioxide business, weak quarterly performance and reduced EPS estimates weighed on investor sentiment, contributing to the bearish trend.
• Strategic moves to strengthen the balance sheet through divestments and leadership changes in key segments were overshadowed by the anticipation of challenging Q4 results, impacting the market sentiment negatively.
• Chemours received an upgrade in its Relative Strength Rating, indicating improving technical performance; however, this positive development was overshadowed by concerns regarding the company's financial performance and operational challenges, leading to the bearish market movement.

03.01.2026 - CC Stock was up 5.1%

• Chemours' stock price has recently increased by 27%, although it remains 14% lower than the previous year, which may suggest undervaluation attracting investor interest.
• The company's low Price-to-Sales (P/S) ratio compared to industry peers indicates a potential value play for investors rather than growth expectations.
• Layoffs at the Georgia mining facilities may signal a strategic shift towards high-value minerals and improved efficiency, seen as a positive move by investors focused on cost-saving measures.
• Concerns around PFAS contamination for private well owners are shedding light on environmental issues within the chemical industry, potentially driving pressure on companies like Chemours to address sustainability and regulatory challenges.
• The recent acquisition of a significant position in Chemours by Y Intercept Hong Kong Ltd signifies confidence in the company's future, despite earnings estimates being missed, showcasing a contrast in market sentiment and institutional support.

26.01.2026 - CC Stock was down 5.4%

• The bearish movement in Chemours (CC) stock today could be attributed to profit-taking by investors after a period of undervaluation.
• The increase in price targets by financial institutions may have initially boosted confidence in the stock, but the market sentiment might have shifted due to concerns about the company's negative net margin and P/E ratio.
• The joint development agreement with 2CRSi for advanced cooling solutions could be a positive long-term catalyst for Chemours, but short-term market dynamics might have overshadowed this news.
• Overall, the bearish movement in CC's stock today seems to reflect a mix of valuation concerns, profit-taking, and short-term market sentiment, despite promising developments in its technology partnerships.

10.01.2026 - CC Stock was up 5.2%

• The stock hit a 52-week high due to strong investor confidence and significant gains over the past six months, despite operating with substantial debt.
• Analysts predict profitability this year, with an EPS of $0.91, reflecting positive sentiment towards the company's financial performance.
• The increased stake by the New York State Common Retirement Fund by over 1,000% in Q3 also contributed to the bullish movement, indicating growing institutional interest in Chemours.
• The announcement of the upcoming fourth-quarter earnings release and conference call may have further boosted investor optimism, providing a catalyst for the stock's upward momentum.